Retrospective Analysis of Primary Septic Arthritis: Epidemiology, Clinical Presentation, Diagnostic Approaches, and Treatment Outcomes at the Rizzoli Orthopaedic Institute (2013-2023 )

Title

Code

SAFER-NJ study

Type

Osservazionale

Start Year

2025

Status

In Corso

Principal Investigator

051-6366252

pietro.cimatti@ior.it

Dr. Cimatti Pietro

Reconstructive Orthopaedic Surgery Innovative Techniques - Musculoskeletal Tissue Bank

Operational unit that carry out the study

complex unit

Chirurgia Ortopedica Ricostruttiva Tecniche Innovative - Banca del Tessuto Muscoloscheletrico (BTM)

Director

Dallari Dante, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. SAFER-NJ study

Monday 3 March 2025, 14:24

PG0003044_2025_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Retrospective Analysis of Primary Septic Arthritis: Epidemiology, Clinical Presentation, Diagnostic Approaches, and Treatment Outcomes at the Rizzoli Orthopaedic Institute (2013-2023 )

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in